Screening of vaginal atrophy in perimenopausal women using VAS combistic and Physician Collected sample

Comparative evaluation for the efficacy of collecting sample by using vaginal atrophy screening combistick (VAS combistick) as against the traditional method of collecting sample for screening of vaginal atrophy in perimenopausal women. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/067170

Enrollment

290

Registered

2024-05-10

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N771- Vaginitis, vulvitis and vulvovaginitis in diseases classified elsewhere

Interventions

Intervention1: Vaginal sample collection using VAS combistick: VAS combistick will be self administered for collection sample. Control Intervention1: Vaginal sample collection by traditional method.:

Eligibility

Inclusion criteria

Inclusion criteria: 1.Perimenopausal women (45-60 years of age). 2.Women reporting at least one vulvo-vaginal atrophy symptom (itching, burning and pain during sex).

Exclusion criteria

Exclusion criteria: 1.Vaginal infection. 2.Intercourse history of last 2 days.

Design outcomes

Primary

Measure	Time frame
To evaluate and compare the accuracy of VMI score & pH using VAS combistick & traditional method.Timepoint: 72 hours	—

Secondary

Measure	Time frame
1.To evaluate the baseline data for vaginal maturation index (VMI) & pH in perimenopausal women. 2. To evaluate and compare the method of collecting sample by using VAS combistick & traditional method 3. To evaluate and compare the feasibility & acceptability using survey based analysis in VAS combistick method and traditional method.Timepoint: 72 hours	—

Countries

India

Contacts

Public ContactNeema Acharya

Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research

neemasacharya@gmail.com9326692511

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026